Kathleen Spring, Ph.D. - Publications

Affiliations: 
2012 Molecular Biology Université de Montréal, Montréal, Canada 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Allard B, Cousineau I, Spring K, Stagg J. Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assays. Methods in Enzymology. 629: 269-289. PMID 31727245 DOI: 10.1016/Bs.Mie.2019.10.007  0.351
2015 Turcotte M, Spring K, Pommey S, Chouinard G, Cousineau I, George J, Chen GM, Gendoo DM, Haibe-Kains B, Karn T, Rahimi K, Le Page C, Provencher D, Mes-Masson AM, Stagg J. CD73 is associated with poor prognosis in high-grade serous ovarian cancer. Cancer Research. PMID 26363007 DOI: 10.1158/0008-5472.Can-14-3569  0.407
2015 Spring K, Fournier P, Lapointe L, Chabot C, Roussy J, Pommey S, Stagg J, Royal I. The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis. Oncogene. PMID 25772245 DOI: 10.1038/Onc.2015.9  0.667
2014 Spring K, Lapointe L, Caron C, Langlois S, Royal I. Phosphorylation of DEP-1/PTPRJ on threonine 1318 regulates Src activation and endothelial cell permeability induced by vascular endothelial growth factor. Cellular Signalling. 26: 1283-93. PMID 24583284 DOI: 10.1016/J.Cellsig.2014.02.008  0.711
2014 Allard B, Turcotte M, Spring K, Pommey S, Royal I, Stagg J. Anti-CD73 therapy impairs tumor angiogenesis. International Journal of Cancer. Journal International Du Cancer. 134: 1466-73. PMID 23982901 DOI: 10.1002/Ijc.28456  0.647
2012 Spring K, Chabot C, Langlois S, Lapointe L, Trinh NT, Caron C, Hebda JK, Gavard J, Elchebly M, Royal I. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation. Blood. 120: 2745-56. PMID 22898603 DOI: 10.1182/Blood-2011-12-398040  0.734
2009 Caron C, Spring K, Laramée M, Chabot C, Cloutier M, Gu H, Royal I. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells. Cellular Signalling. 21: 943-53. PMID 19233262 DOI: 10.1016/J.Cellsig.2009.02.004  0.72
2009 Chabot C, Spring K, Gratton JP, Elchebly M, Royal I. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Molecular and Cellular Biology. 29: 241-53. PMID 18936167 DOI: 10.1128/Mcb.01374-08  0.725
2000 Yang T, Park JM, Arend L, Huang Y, Topaloglu R, Pasumarthy A, Praetorius H, Spring K, Briggs JP, Schnermann J. Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line. The Journal of Biological Chemistry. 275: 37922-9. PMID 10982805 DOI: 10.1074/Jbc.M006218200  0.341
2000 Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, Mattern MR, Winkler JD, Khanna KK. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. The Journal of Biological Chemistry. 275: 10342-8. PMID 10744722 DOI: 10.1074/jbc.275.14.10342  0.348
1997 Zhang N, Chen P, Khanna KK, Scott S, Gatei M, Kozlov S, Watters D, Spring K, Yen T, Lavin MF. Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proceedings of the National Academy of Sciences of the United States of America. 94: 8021-6. PMID 9223307 DOI: 10.1073/pnas.94.15.8021  0.302
Show low-probability matches.